Saitama, Japan

Eiji Komatsu

This inventor holds 1 USPTO granted patent. Top assignee: Kitasato Daiichi Sankyo Vaccine Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eiji Komatsu. Retrieved from https://idiyas.com/inventor/eiji-komatsu-zo439w7e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eiji Komatsu - Innovator in Vaccine Development

Eiji Komatsu is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of vaccine development, particularly in the area of whooping cough prevention. His work is characterized by a commitment to advancing public health through innovative solutions.

Latest Patents

Eiji Komatsu holds a patent for a whole-cell bacterial vaccine composition aimed at preventing whooping cough. The objective of this invention is to provide a vaccine that comprises whole cells, whole-cell homogenate, or cell lysate as an immunogen. This innovative approach is crucial for enhancing the effectiveness of vaccines against this respiratory disease.

Career Highlights

Eiji Komatsu is associated with Kitasato Daiichi Sankyo Vaccine Co., Ltd., where he applies his expertise in vaccine research and development. His role at the company allows him to contribute to the advancement of immunization strategies that can save lives and improve health outcomes.

Collaborations

Eiji Komatsu collaborates with Mineo Watanabe, another professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in vaccine technology.

Conclusion

Eiji Komatsu's work in vaccine development highlights his dedication to improving public health through innovative solutions. His contributions, particularly in the area of whooping cough prevention, are vital for advancing medical science and protecting communities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…